CardioVia ^{For Profit}

CardioVia is a company that is developing minimal invasive access to the outer surface of the heart via the pericardium which is a double-walled sac that surrounds the heart. The outer surface of the heart has been recognized as a promising entry route for the treatment of the most prevalent cardiovascular diseases such as cardiac tamponade, mapping & ablation for various arrhythmias such as Atrial fibrillation and Ventricular tachycardia, left atrial appendage closure, epicardial lead placement and in the future, epicardial pacemaker implantation, drug, stem cells and gene therapy. The company is using cutting edge technologies with the simplest ideas to provide physicians with the right access to perform advanced cardiac treatments on the outer surface of the heart like never seen before. The company's device is able to perform an accurate entrance between the layers of the pericardium thanks to cutting edge technologies while changing the way we think about the access. The procedure is performed in a controlled and measured manner, while synchronizing with the heartbeats and the system allows penetration to the outer surface of the pericardial space without the risk of puncturing the heart muscle. Contact_info: ziv@cardiovia.com or@cardiovia.com | Nazareth, Israel